全文获取类型
收费全文 | 25018篇 |
免费 | 2065篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 940篇 |
妇产科学 | 755篇 |
基础医学 | 3603篇 |
口腔科学 | 441篇 |
临床医学 | 3313篇 |
内科学 | 4389篇 |
皮肤病学 | 310篇 |
神经病学 | 2934篇 |
特种医学 | 624篇 |
外科学 | 2190篇 |
综合类 | 281篇 |
一般理论 | 46篇 |
预防医学 | 3070篇 |
眼科学 | 407篇 |
药学 | 1949篇 |
中国医学 | 28篇 |
肿瘤学 | 1694篇 |
出版年
2023年 | 208篇 |
2022年 | 128篇 |
2021年 | 518篇 |
2020年 | 393篇 |
2019年 | 592篇 |
2018年 | 648篇 |
2017年 | 522篇 |
2016年 | 553篇 |
2015年 | 627篇 |
2014年 | 897篇 |
2013年 | 1277篇 |
2012年 | 1793篇 |
2011年 | 1865篇 |
2010年 | 1009篇 |
2009年 | 939篇 |
2008年 | 1563篇 |
2007年 | 1687篇 |
2006年 | 1666篇 |
2005年 | 1560篇 |
2004年 | 1516篇 |
2003年 | 1374篇 |
2002年 | 1315篇 |
2001年 | 319篇 |
2000年 | 278篇 |
1999年 | 276篇 |
1998年 | 279篇 |
1997年 | 244篇 |
1996年 | 204篇 |
1995年 | 197篇 |
1994年 | 157篇 |
1993年 | 167篇 |
1992年 | 168篇 |
1991年 | 145篇 |
1990年 | 134篇 |
1989年 | 122篇 |
1988年 | 107篇 |
1987年 | 101篇 |
1986年 | 87篇 |
1985年 | 92篇 |
1984年 | 83篇 |
1983年 | 87篇 |
1982年 | 99篇 |
1981年 | 73篇 |
1980年 | 83篇 |
1979年 | 68篇 |
1978年 | 64篇 |
1977年 | 62篇 |
1976年 | 69篇 |
1975年 | 63篇 |
1974年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Aliyah Hussein Kiran Sran Imran Ali Janine Woellner Helen Wilcox Stephen D. Marks Helen Jones Chris Callaghan 《Pediatric transplantation》2020,24(4)
Transplant ureteric stent insertion reduces the incidence of MUCs, but it is not known whether routine PSRGU is needed to detect unmasked MUCs. This study evaluated whether routine PSRGU in the pRTR is a useful tool to identify MUCs before they become clinically apparent. A retrospective analysis was undertaken of the clinical outcomes following elective stent removal from pediatric kidney‐only transplant recipients at two London centers between 2012 and 2016. Our policy was to perform PSRGU either routinely or urgently if there were concerning symptoms or biochemical evidence of renal allograft dysfunction. Elective stent removal was performed in 86% (97 of 113 pRTR), and 75 (77%) of whom had routine PSRGU at a median (IQR) of 6 (2‐8) days after stent removal. There were changes to management in 3 (4%) of pRTR with PSRGU identifying no MUC. Nineteen patients (25%) had urgent PSRGU, most commonly due to renal allograft dysfunction, at a median (IQR) of 5.5 (2.7‐12.3) days after stent removal. Of these, two pRTR required ureteric intervention. For our current practice of removing transplant stents at 4‐6 weeks post‐transplantation, our study has found no evidence to support routine PSRGU after elective stent removal. 相似文献
2.
3.
4.
5.
6.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
7.
8.
9.
10.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691